Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-40,400
Closed -$3.43M 861
2019
Q4
$3.43M Buy
40,400
+6,000
+17% +$400K 0.19% 106
2019
Q3
$1.72M Sell
34,400
-19,200
-36% -$766K 0.11% 153
2019
Q2
$1.95M Buy
53,600
+28,900
+117% +$943K 0.11% 148
2019
Q1
$691K Sell
24,700
-3,100
-11% -$73.1K 0.04% 261
2018
Q4
$532K Buy
27,800
+2,100
+8% +$48.9K 0.04% 277
2018
Q3
$769K Buy
25,700
+15,000
+140% +$565K 0.03% 252
2018
Q2
$393K Buy
+10,700
New +$348K 0.02% 331
2017
Q2
Sell
-11,000
Closed -$538K 718
2017
Q1
$538K Buy
11,000
+8,000
+267% +$365K 0.03% 319
2016
Q4
$102K Sell
3,000
-5,000
-63% -$177K 0.01% 609
2016
Q3
$302K Sell
8,000
-12,700
-61% -$479K 0.01% 477
2016
Q2
$696K Buy
20,700
+5,000
+32% +$176K 0.05% 289
2016
Q1
$499K Buy
+15,700
New +$513K 0.03% 340
2015
Q4
Sell
-2,500
Closed -$95K 793
2015
Q3
$95K Buy
+2,500
New +$87.8K 0.01% 673

Other funds holding MDCO

CSS LLC's MDCO Position: Q1 2020 in Review

CSS LLC sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 22,000 shares — an estimated $1.87M sold.

CSS LLC first reported a position in MDCO in Q4 2018 and held it in 2 quarters. The position peaked at $1.87M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • CSS LLC reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • CSS LLC sold 22,000 Medicines Co shares in Q1 2020, an estimated $1.87M.
  • CSS LLC first reported a position in Medicines Co in Q4 2018 and held it in 2 quarters.
  • CSS LLC's Medicines Co position peaked at $1.87M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on CSS LLC's 13F filing for Q1 2020, filed 15 May 2020.